Swiss Re proposes solutions to longevity funding issues

Swiss Re report calls on insurers, governments and pension providers to grasp the nettle of longevity funding issues.

In a report entitled “A short guide to longer lives: Longevity funding issues and potential solutions,” Swiss Re says that prompt concerted action in the form of public-private partnerships needs to be at the heart of strategies to tackle the risks associated with increased life expectancy.

In a recent analysis, United Nations experts say that “population ageing is without parallel in the history of humanity.”  At the world level, the report goes on, the number of people over 60 is expected to exceed the number under 15 for the first time in 2045. In the more developed regions, where population ageing is far advanced, the number of children dropped below that of older persons in 1998.

The so-called Methuselah effect is set to have a profound impact on many aspects of human life - on economic growth, savings, investment, consumption, labour markets, life styles, taxation, healthcare and pensions.

Global ageing is a wonderful success story. The fact people are living longer and generally healthier lives is a triumph of medical progress and economic development over disease, factors which have constrained human life expectancy for thousands of years.  But this phenomenon does pose massive challenges, not least of which lie in the area of pension funding. Longevity risk means that pension plans could face shortfalls resulting from increased life expectancy. This is in addition to the declines in asset values triggered by the economic downturn. And this is one of the problems that Swiss Re addresses in its report (See 'A short guide to longer lives' at the right).

But the study not only highlights the issues involved – such as the negative impact on pension liabilities caused by under-estimating life expectancy – it also makes recommendations and proposes solutions. And not just on paper.  A case in point was the recent longevity transaction Swiss Re structured for a British pension fund. The transaction provides the UK’s Royal County of Berkshire Pension Fund (RBPF) protection against the uncertainty associated with retirees’ rising life expectancy. The longevity risk involved amounts to CHF 1.7 billion of pensioner liabilities.

Says Head of Swiss Re’s Life & Health Division, Alison Martin: “While life expectancy is on the increase, the time required for implementing effective longevity funding solution is running out. Insurers, governments and pension providers must act now to ensure that living longer remains a benefit to society rather than a financial burden.”

Published: 31 August 2010

Longevity risk means that pension plans could face shortfalls resulting from increased life expectancy. This is in addition to the declines in asset values triggered by the economic downturn.


Computer enhanced image of a DNA string

Planning for longer lives

Medical advances have helped increase life expectancy, but with this good news comes challenges in retirement financing. Governments, insurers and pension funds should work together to help plan for longer...
Read the whole story

Driving the debate on longer lives

Declines in birth rates and increases in life expectancy in the last century have meant there is a larger proportion of older people in most countries. A new World Economic Forum (WEF) publication explores...
Read the whole story

"Rapidly increasing longevity is threatening to undermine the viability of some schemes"

Podcast interview with Lord Hutton, Chair of Independent Public Service Pensions Commission, UK
Listen here
A short guide to longer lives

A short guide to longer lives

Find out more about longevity funding issues and potential solutions by downloading our report.
Find out more
Swiss Re Centre for Global Dialogue

Swiss Re Centre for Global Dialogue

Read more about Ageing and Longevity in the CGD's Risk Dialogue Magazine
Find out more
© 2012 Swiss Re. All Rights Reserved | Swiss Re Share SREN CHF 53.2 | Legal notice | Privacy policy | Main: + 41 43 285 2121